Essex Bio-Technology Ltd
HKEX:1061
Essex Bio-Technology Ltd
Cash from Operating Activities
Essex Bio-Technology Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Essex Bio-Technology Ltd
HKEX:1061
|
Cash from Operating Activities
HK$339.2m
|
CAGR 3-Years
4%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
H
|
Hbm Holdings Ltd
HKEX:2142
|
Cash from Operating Activities
-$100m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
C
|
China Regenerative Medicine International Ltd
HKEX:8158
|
Cash from Operating Activities
-HK$7.5m
|
CAGR 3-Years
73%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Uni-Bio Science Group Ltd
HKEX:690
|
Cash from Operating Activities
HK$69.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CK Life Sciences Intl (Holdings) Inc
HKEX:775
|
Cash from Operating Activities
HK$230.1m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
See Also
What is Essex Bio-Technology Ltd's Cash from Operating Activities?
Cash from Operating Activities
339.2m
HKD
Based on the financial report for Dec 31, 2023, Essex Bio-Technology Ltd's Cash from Operating Activities amounts to 339.2m HKD.
What is Essex Bio-Technology Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
11%
Over the last year, the Cash from Operating Activities growth was -11%. The average annual Cash from Operating Activities growth rates for Essex Bio-Technology Ltd have been 4% over the past three years , 11% over the past five years .